Peritoneovenous shunt
Peritoneovenous Shunt is a medical procedure used to treat ascites, which is the accumulation of fluid in the peritoneal cavity causing abdominal swelling. Ascites can result from various conditions, most commonly liver cirrhosis, heart failure, or cancer. The peritoneovenous shunt, also known as a LeVeen shunt, after its inventor, is designed to reroute ascitic fluid from the peritoneal cavity back into the venous system, thereby relieving the symptoms associated with ascites.
Indications[edit | edit source]
The primary indication for a peritoneovenous shunt is refractory ascites, which is ascites that cannot be managed by medical therapy alone, including dietary sodium restriction and diuretic therapy. Patients with malignant ascites, hepatic hydrothorax, and those who are not candidates for or have failed liver transplantation may also be considered for this procedure.
Procedure[edit | edit source]
The peritoneovenous shunt procedure involves the surgical insertion of a shunt, which is a tube that connects the peritoneal cavity to a vein, typically the superior vena cava or the jugular vein. This allows the ascitic fluid to be absorbed into the bloodstream. The shunt contains a one-way valve to prevent the backflow of blood into the peritoneal cavity.
Complications[edit | edit source]
Complications of the peritoneovenous shunt procedure can include shunt occlusion, infection, deep vein thrombosis, and pulmonary embolism. There is also a risk of inducing hepatic encephalopathy due to the increased load of substances from the ascitic fluid entering the systemic circulation, which the liver may not be able to adequately detoxify.
Outcomes[edit | edit source]
The effectiveness of peritoneovenous shunting in relieving the symptoms of ascites is significant; however, it does not address the underlying cause of the ascites. Therefore, it is considered a palliative treatment. The procedure can improve the quality of life for patients with refractory ascites, but it is associated with a high complication rate, which has led to a decline in its use in favor of other treatments such as paracentesis and transjugular intrahepatic portosystemic shunt (TIPS).
See Also[edit | edit source]
Search WikiMD
Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro / Zepbound) available.
Advertise on WikiMD
WikiMD's Wellness Encyclopedia |
Let Food Be Thy Medicine Medicine Thy Food - Hippocrates |
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
Medical Disclaimer: WikiMD is not a substitute for professional medical advice. The information on WikiMD is provided as an information resource only, may be incorrect, outdated or misleading, and is not to be used or relied on for any diagnostic or treatment purposes. Please consult your health care provider before making any healthcare decisions or for guidance about a specific medical condition. WikiMD expressly disclaims responsibility, and shall have no liability, for any damages, loss, injury, or liability whatsoever suffered as a result of your reliance on the information contained in this site. By visiting this site you agree to the foregoing terms and conditions, which may from time to time be changed or supplemented by WikiMD. If you do not agree to the foregoing terms and conditions, you should not enter or use this site. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates Wikipedia, licensed under CC BY SA or similar.
Contributors: Prab R. Tumpati, MD